Unknown

Dataset Information

0

Ethical approval for controlled human infectious model clinical trial protocols - A workshop report.


ABSTRACT: Controlled Human Infectious Model studies (CHIM) involve deliberately exposing volunteers to pathogens. To discuss ethical issues related to CHIM, the European Vaccine Initiative and the International Alliance for Biological Standardization organised the workshop "Ethical Approval for CHIM Clinical Trial Protocols", which took place on May 30-31, 2023, in Brussels, Belgium. The event allowed CHIM researchers, regulators, ethics committee (EC) members, and ethicists to examine the ethical criteria for CHIM and the role(s) of CHIM in pharmaceutical development. The discussions led to several recommendations, including continued assurance that routine ethical requirements are met, assurance that participants are well-informed, and that preparation of study documents must be both ethically and scientifically sound from an early stage. Study applications must clearly state the rationale for the challenge compared to alternative study designs. ECs need to have clear guidance and procedures for evaluating social value and assessing third-party risks. Among other things, public trust in research requires minimisation of harm to healthy volunteers and third-party risk. Other important considerations include appropriate stakeholder engagement, public education, and access to health care for participants after the study.

SUBMITTER: Jamrozik E 

PROVIDER: S-EPMC11004724 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ethical approval for controlled human infectious model clinical trial protocols - A workshop report.

Jamrozik Euzebiusz E   Littler Katherine K   Meln Irina I   Van Molle Wim W   Morel Sandra S   Olesen Ole F OF   Rubbrecht Michelle M   Balasingam Shobana S   Neels Pieter P  

Biologicals : journal of the International Association of Biological Standardization 20240212


Controlled Human Infectious Model studies (CHIM) involve deliberately exposing volunteers to pathogens. To discuss ethical issues related to CHIM, the European Vaccine Initiative and the International Alliance for Biological Standardization organised the workshop "Ethical Approval for CHIM Clinical Trial Protocols", which took place on May 30-31, 2023, in Brussels, Belgium. The event allowed CHIM researchers, regulators, ethics committee (EC) members, and ethicists to examine the ethical criteri  ...[more]

Similar Datasets

| S-EPMC7100954 | biostudies-literature
| S-EPMC7996078 | biostudies-literature
| S-EPMC6816368 | biostudies-literature
| S-EPMC11683251 | biostudies-literature
| S-EPMC4819642 | biostudies-literature
| S-EPMC2561118 | biostudies-literature
| S-EPMC5986297 | biostudies-other
| S-EPMC7875449 | biostudies-literature
| S-EPMC5027113 | biostudies-literature
| S-EPMC9167544 | biostudies-literature